Real-World Data from Three Separate Studies Demonstrate that Valeritas’ V-Go® Significantly Reduces A1c and Lowers Total Daily Insulin Dose for Patients with Diabetes decca Federal Court rules in favor of Teladoc, blocking Texas Medical Board rule and preserving telehealth in Texas Teladoc service to millions of Texans continues uninterrupted AbilTo Closes $12Million in Series C Funding Led By HLM Venture Partners
